• No results found

CERVICAL CANCER SCREENING

N/A
N/A
Protected

Academic year: 2021

Share "CERVICAL CANCER SCREENING"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

(1)

CERVICAL CANCER SCREENING

APPLICATIONS

HEDIS

®

(Hybrid)

NCQA Accreditation

NCQA Rating

Member Incentive*

Kyhealthnow 2019 goal**

OBJECTIVE

Purpose of Measure:

To identify members who are due for a cervical

cancer screening and HPV co-testing

ELIGIBLE POPULATION

Which members are included?

Women 21-64 years of age as of December

31st of the measurement year.

Women who have had a complete, total, or

radical hysterectomy (acquired absence of

cervix) or a diagnosis of cervical agenesis are

excluded. Also following meets exclusion

criteria:

Documentation of a “vaginal pap

smear” in conjunction with

documentation of “hysterectomy”

Documentation of hysterectomy in

combination with documentation that

the patient no longer needs pap

testing/cervical cancer screening.

STANDARD OF CARE

What screening should be

done?

At least one (1) pap test every three (3) years

for women age 21-64 years.

Women age 30-64 may have cervical cytology

and human papillomavirus (HPV) co-testing at

least every five (5) years.

NCQA ACCEPTED CODES

Please see code table.

DOCUMENTATION

REQUIREMENTS

What documentation should

be submitted?

If screening was done:

Lab results for pap test and HPV test

(when applicable) or

Documentation in the medical record

indicating when the pap and HPV

screenings, when applicable, were done

and the result(s) or finding(s).

If screening was not done:

(2)

indicating the member had a

hysterectomy with no residual cervix.

Documentation of “complete,” “total,”

or “radical” abdominal or vaginal

hysterectomy meets criteria.

Documentation of “hysterectomy” in

conjunction with a vaginal pap smear.

Documented diagnosis of cervical

agenesis.

Documentation of hysterectomy in

combination with documentation that

the patient no longer needs pap

testing/cervical cancer screening.

Documentation of hysterectomy alone

does not meet criteria because it is not

sufficient evidence that the cervix was

removed.

REFERENCES

For more information, please refer to Passport

Health Plan’s Preventive Health

Clinical

Practice Guideline.

The criteria above are based on standards established under NCQA’s

HEDIS

2016 Technical Specifications. HEDIS

is a registered trademark of

the National Committee for Quality Assurance (NCQA).

* For more information on member incentives, please contact Fran Crawford,

Manager of Passport’s Rapid Response Department at 502-585-7907.

** Governor Steve Beshear has made improving the health and wellness of

Kentucky’s children, families and workforce one of his highest priorities. To

significantly advance the wellbeing of Kentucky’s citizens, Governor Beshear

announced several health goals for the Commonwealth in February 2014. He

outlined a number of strategies to help achieve these goals over the next five

years, and will continue to add strategies throughout his term. These strategies

will be implemented through executive and legislative actions, public-private

partnerships and through the success of enrolling Kentuckians in health care

coverage.

(3)

CERVICAL CANCER SCREENING

Meet Screening Criteria

Code System

Code

Definition

CPT 88141 Cervical Cytology CPT 88142 Cervical Cytology CPT 88143 Cervical Cytology CPT 88147 Cervical Cytology CPT 88148 Cervical Cytology CPT 88150 Cervical Cytology CPT 88152 Cervical Cytology CPT 88153 Cervical Cytology CPT 88154 Cervical Cytology CPT 88164 Cervical Cytology CPT 88165 Cervical Cytology CPT 88166 Cervical Cytology CPT 88167 Cervical Cytology CPT 88174 Cervical Cytology CPT 88175 Cervical Cytology

HCPCS G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by

cytotechnologist under physician supervision (G0123)

HCPCS G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician (G0124)

HCPCS G0141 Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician (G0141) HCPCS G0143 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision (G0143)

HCPCS G0144 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by

automated system, under physician supervision (G0144)

HCPCS G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by

automated system and manual rescreening under physician supervision (G0145) HCPCS G0147 Screening cytopathology smears, cervical or vaginal, performed by automated

system under physician supervision (G0147)

HCPCS G0148 Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening (G0148)

HCPCS P3000 Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision (P3000)

HCPCS P3001 Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician (P3001)

(4)

or vaginal smear to laboratory (Q0091)

LOINC 10524-7 Microscopic observation [Identifier] in Cervix by Cyto stain

LOINC 18500-9 Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

LOINC 19762-4 General categories [interpretation] of Cervical or vaginal smear or scraping by Cyto stain

LOINC 19764-0 Statement of adequacy [interpretation] of Cervical or vaginal smear or scraping by Cyto stain

LOINC 19765-7 Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain

LOINC 19766-5 Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative

LOINC 19774-9 Cytology study comment Cervical or vaginal smear or scraping Cyto stain LOINC 33717-0 Cytology Cervical or vaginal smear or scraping study

LOINC 47527-7 Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep LOINC 47528-5 Cytology report of Cervical or vaginal smear or scraping Cyto stain

UBREV 0923 Cervical Cytology

CPT 87620 HPV Test

CPT 87621 HPV Test

CPT 87622 HPV Test

LOINC 21440-3 Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by DNA probe

LOINC 30167-1 Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe and signal amplification method

LOINC 38372-9 Human papilloma virus

6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe and signal amplification method

LOINC 49896-4 Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Unspecified specimen by Probe and target amplification method LOINC 59420-0 Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA

[Presence] in Cervix by Probe and signal amplification method

LOINC 75406-9 Human papilloma virus 16 and 18+45 E6+E7 mRNA [Presence] in Cervix by Probe with amplification

LOINC 75694-0 Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by Probe and signal amplification method

Exclusions

Code System

Code

Definition

CPT 51925 Absence of Cervix CPT 56308 Absence of Cervix CPT 57540 Absence of Cervix CPT 57545 Absence of Cervix CPT 57550 Absence of Cervix CPT 57555 Absence of Cervix CPT 57556 Absence of Cervix CPT 58150 Absence of Cervix CPT 58152 Absence of Cervix CPT 58200 Absence of Cervix

(5)

CPT 58210 Absence of Cervix CPT 58240 Absence of Cervix CPT 58260 Absence of Cervix CPT 58262 Absence of Cervix CPT 58263 Absence of Cervix CPT 58267 Absence of Cervix CPT 58270 Absence of Cervix CPT 58275 Absence of Cervix CPT 58280 Absence of Cervix CPT 58285 Absence of Cervix CPT 58290 Absence of Cervix CPT 58291 Absence of Cervix CPT 58292 Absence of Cervix CPT 58293 Absence of Cervix CPT 58294 Absence of Cervix CPT 58548 Absence of Cervix CPT 58550 Absence of Cervix CPT 58552 Absence of Cervix CPT 58553 Absence of Cervix CPT 58554 Absence of Cervix CPT 58570 Absence of Cervix CPT 58571 Absence of Cervix CPT 58572 Absence of Cervix CPT 58573 Absence of Cervix CPT 58951 Absence of Cervix CPT 58953 Absence of Cervix CPT 58954 Absence of Cervix CPT 58956 Absence of Cervix CPT 59135 Absence of Cervix

ICD10CM Q51.5 [Q51.5] Agenesis and aplasia of cervix

ICD10CM Z90.710 [Z90.710] Acquired absence of both cervix and uterus ICD10CM Z90.712 [Z90.712] Acquired absence of cervix with remaining uterus ICD10PCS 0UTC0ZZ [0UTC0ZZ] Resection of Cervix, Open Approach

ICD10PCS 0UTC4ZZ [0UTC4ZZ] Resection of Cervix, Percutaneous Endoscopic Approach ICD10PCS 0UTC7ZZ [0UTC7ZZ] Resection of Cervix, Via Natural or Artificial Opening

ICD10PCS 0UTC8ZZ [0UTC8ZZ] Resection of Cervix, Via Natural or Artificial Opening Endoscopic ICD9CM 618.5 Prolapse of vaginal vault after hysterectomy

ICD9CM 752.43 Cervical agenesis

ICD9CM V88.01 Acquired absence of both cervix and uterus ICD9CM V88.03 Acquired absence of cervix with remaining uterus ICD9PCS 68.41 Laparoscopic total abdominal hysterectomy

ICD9PCS 68.49 Other and unspecified total abdominal hysterectomy ICD9PCS 68.51 Laparoscopically assisted vaginal hysterectomy (LAVH)

(6)

ICD9PCS 68.59 Other and unspecified vaginal hysterectomy

ICD9PCS 68.61 Laparoscopic radical abdominal hysterectomy

ICD9PCS 68.69 Other and unspecified radical abdominal hysterectomy ICD9PCS 68.71 Laparoscopic radical vaginal hysterectomy [LRVH] ICD9PCS 68.79 Other and unspecified radical vaginal hysterectomy

References

Related documents

Sexy media matter: ex- posure to sexual content in music, movies, television, and magazines predicts black and white adolescents’ sexual behavior. Bersamin M, Todd M, Fisher DA,

The co-located setting provided both cues on the right hand of the users; whereas the dislocated setting delivered the force and vibrotactile cues on the right hand and forearm

Σύμφωνα με τη δήλωση 4 , η οποία πραγματοποιήθηκε κατά την έγκριση του κανονισμού επιτροπολογίας, ότι όλες οι διατάξεις σχετικά με την ΚΔΕ σε υφιστάμενες βασικές

study objectives or physic al characteristics of the test preparation. For example, applications to the skin surt'acc may be i nfinite , where large volumes per unit

Professor of Anesthesiology & Pain Medicine Adjunct Professor of Pediatrics and Psychiatry University of Washington School of Medicine Director of Pain Medicine.

Literature records of weaver ant host plants from 1945 to 2016 showed that Camponotus textor Forel (= Camponotus senex ), the Brazilian savanna weaver ant, was recorded on 17

The policy recommendations would therefore be to remove obstacles to ‡exibility in labour markets: decrease unemploy- ment bene…ts, weaken job protection legislation, increase